Ledger.Open graph →
SEC Form D · filed February 19, 2021

Graviton BioScience Corp

Offering
$30.0M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Steven Gordon · New York, NYExec · DirectorSamuel Waksal · New York, NYDirectorRichard Giroux · New York, NYDirectorPhilip Barach · Los Angeles, CADirectorSteven Gordon · New York, NYExec · DirectorRichard Giroux · New York, NYDirectorSamuel Waksal · New York, NYDirectorPhilip Barach · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗